As clinical trials, drug development, collaboration, licensing arrangements and pharmacovigilance expands in Greece, data protections issues will increase in importance. An enhanced understanding of the Greek data protection framework will be necessary, particularly as respects collection and transfer abroad of medical and clinical data stored or originating in Greece. Clinical trial researchers, sponsors and others will want to be aware of and ensure that appropriate precautions have been observed and that use of the data is permitted.